InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,478.00
(
0.24%
)
US TECH 100
19,112.80
(
-0.49%
)
Dow Jones
39,477.33
(
0.84%
)
Brent Oil
85.23
(
1.43%
)
Bitcoin
60,258.89
(
-4.59%
)
Post# of 252319
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 97527

Monday, 06/21/2010 10:49:49 AM

Monday, June 21, 2010 10:49:49 AM

Post# of 252319
Re Oppenheimer MS survey

73% of neurologists thought use of Copaxone could
decrease. On ave. Copaxone use could decline by 18.6% if gilenia is approved. They estimate Teva's 2011 EPS could drop 6.5% if gilenia is approved.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up